Top Pharma and MedTech AI Development Companies: Who Builds What and for Whom

HIPAA compliance is the floor in healthcare software. In pharma and MedTech, the regulatory stack goes several levels higher: FDA SaMD classification, GxP validation, 21 CFR Part 11, ISO 13485. Each carries its own documentation requirements, validation protocols, and submission processes that a standard healthcare development team may have never encountered.

This guide covers top AI development companies for pharma and MedTech, organized by use case and selected based on verified experience in GxP, SaMD, and clinical trial environments.

The Best Pharma and MedTech AI Companies by Specialization

The vendors below are organized by their focus, as a firm that excels at drug discovery AI may have no experience with medical device software, and vice versa. Match the segment to your use case first, then evaluate the vendors within it.

Drug Discovery and Clinical Trial AI Partners 

Drug discovery and clinical trial AI must meet data integrity requirements under ICH E6(R3), audit trail obligations under 21 CFR Part 11, and, in some cases, FDA SaMD classification, depending on how outputs are used clinically. The vendors below have delivered production AI in this environment.

Relevant Software: Top AI Development Company for Clinical Data Analytics and Trial Intelligence

• Headquarters: Ukraine, with offices in Poland and Spain.
• Founded: 2013.
• Best for: Pharma and life sciences organizations that need custom AI systems for clinical data processing, trial analytics, and real-world evidence platforms.

Relevant Software is an international technology consulting and development company with 12+ years in operation and 246 delivered projects. Their clients include Fortune 500 companies, global pharma organizations, and fast-growing life sciences startups. They act as a full-cycle partner, covering architecture consulting, development, integration, validation support, and long-term maintenance.

• Regulatory compliance. HIPAA, ISO 27001, and GDPR are enforced at the data pipeline level. Engineering practices include ePHI handling, audit logging, and data minimization by design. With 92% senior engineers and a 96% retention rate, they provide the continuity needed for long validation and submission cycles.
• Pharma and MedTech AI solutions. Relevant Software builds clinical data analytics platforms, predictive models for patient outcomes and risk stratification, real-world evidence infrastructure, and FHIR-native data architecture linking trial platforms to EHR and lab systems. Their AI spans the full data lifecycle: ingestion, normalization, processing, and insight delivery.
• Notable clients and projects. Clients include AstraZeneca, one of the most demanding reference points for pharma AI. For Highscale-Impact GmbH, they built an AI analytics platform that processes millions of records daily and returns real-time, plain-language insights.

Quantori: Life Sciences Development Built Around Scientific Domain Expertise

• Headquarters: Cambridge, Massachusetts.
• Founded: 2020.
• Best for: Biopharma and biotech organizations that need AI and data engineering grounded in drug discovery, clinical informatics, precision medicine, and registry science.

Quantori is a life sciences–focused AI and data engineering company founded by EPAM Systems alumni. With 750+ data scientists and engineers, they operate at the intersection of software development and scientific research, giving pharma clients access to teams that understand GxP from a domain perspective.

• Regulatory compliance. Quantori guided a global cancer diagnostics company through full CAP and CLIA certification for their LIMS, covering UAT, compliance documentation, and requirement tracking across all components, including genomic data treated as a medical device.
• Pharma and MedTech AI solutions. Q-Suite includes Q-Portal (a governed, compliance-aware LLM environment), Q-Data (an enterprise data platform that unifies fragmented life sciences data), and Q-Image (an AI imaging platform that integrates longitudinal data into 4D models).
• Notable clients and projects. Through a Databricks partnership, Quantori helps life sciences organizations unify drug lifecycle data across cloud platforms. Clients describe them as a trusted multi‑year partner for data engineering, software development, DevOps, and data science team augmentation.

BioSistemika: ISO-Validated Laboratory Software for Pharma and MedTech

• Headquarters: Ljubljana, Slovenia (clients across Europe and the U.S.)
• Founded: 2010
• Best for: Pharma and MedTech companies that need custom laboratory software built to regulatory standards (instrument manufacturers, lab digitalization, and medical device software under IVDR).

BioSistemika is a lab software development company spun off from Slovenia’s National Institute of Biology. Their teams pair engineers with laboratory scientists so software reflects how regulated labs actually operate. Their practice centers on ISO-certified validation, QA documentation, and regulatory-compliant delivery for instrument providers and pharma organizations.

• Regulatory compliance. BioSistemika develops medical device software and documentation in line with IVDR, covering requirements, risk assessment, coding, implementation, and validation. Their documentation practice supports the full submission trail: URS, SRS, and Software Design Specifications.
• Pharma and MedTech AI solutions. Work spans lab automation, qPCR software, bioinformatics, workflow management, algorithm development, and big data storage. On the AI side, they build analytics and digitalization platforms that integrate with existing instrument ecosystems across pharma and life sciences.
• Notable clients and projects. BioSistemika has worked with Gilson, Agilent, Alifax, and ADInstruments on custom software and digitalization. Their DATANA project, funded by the European Innovation Council and supported by NATO’s DIANA program, places them at the forefront of life sciences data infrastructure innovation.

Medical Device Software and SaMD AI Partners 

In the U.S., the FDA treats AI‑powered diagnostic and clinical decision tools as medical devices, requiring 510(k) clearance or De Novo submission based on risk. In Europe, MDR applies similar rules. IEC 62304 governs the software lifecycle, ISO 13485 governs quality management, and ISO 14971 governs documented risk management for any system that influences clinical decisions. The vendors below have the certification stack and documentation experience to support FDA and MDR submissions.

ScienceSoft: FDA 510(k) Documentation and IEC 62304 Development for Medical Device Software

• Headquarters: McKinney, Texas (global engineering team).
• Founded: 1989 (healthcare IT since 2005).
• Best for: Medical device manufacturers and MedTech companies that need FDA 510(k) or CE/MDR submission-ready software developed to ISO 13485 and IEC 62304 standards.

ScienceSoft is a U.S.-headquartered technology company with 20+ years in healthcare IT and a dedicated medical device software practice. Their services are backed by ISO 13485 certification, decades of healthcare experience, and an MD-level healthcare IT consultant, plus experience in FDA registration, CE marking, and HIPAA/HITECH-compliant development.

• Regulatory compliance. Development follows ISO 13485, IEC 62304, and IEC 82304-1, with detailed documentation (including Design History Files) for FDA 510(k), CE/MDR/IVDR submissions, and HIPAA audits. Documentation covers ISO 13485, ISO/IEC 82304-1, IEC 62304, GxP, and 21 CFR Part 820, with Technical Files for the EU and Design History Files, Device Master Records, and Device History Records for the U.S.
• Pharma and MedTech AI solutions. ScienceSoft supports medical imaging analysis, IoMT remote patient monitoring, diagnostics software, and in vitro diagnostics platforms. They helped a global AI imaging provider add a new image-generation module and achieve GDPR, ISO 13485, and IEC 62304 compliance within 3 months.
• Notable clients and projects. ScienceSoft built laboratory diagnostics software for genetic screening and QA, and in 2 months delivered a desktop app for lung cancer detection to a U.S. biotech company, ensuring 100% stable generation of comprehensive diagnostic reports from flow cytometry data.

HTD Health: Compliant Agile SaMD Development With FDA 510(k) Submission Support

• Headquarters: Chicago, Illinois.
• Founded: 2014.
• Best for: MedTech startups and digital health companies building Software-as-a-Medical-Device.

HTD Health is a dedicated SaMD development firm led by a team with biomedical engineering and public health backgrounds. Their MedTech Practice Lead holds a Doctorate in Public Health focused on SaMD development. This is an unusual credential for a development company.

• Regulatory compliance. HTD Health supports FDA 510(k) application and De Novo classification for Class I and II devices, and FDA approval for Class III devices, using Greenlight Guru as their internal eQMS to manage the entire medical device software lifecycle. Their compliance stack covers IEC 62304, IEC 82304, UL 2900, GDPR, and SOC 2 Type 1.
• Pharma and MedTech AI solutions. HTD pioneered a Compliant Agile Development framework that integrates IEC 62304 standard requirements and FDA guidelines with Agile development methodologies, operating across the product, release, sprint, and user story levels to maintain traceability and compliance. Their AI work covers connected medical devices, wearables, IoMT systems, and AI-driven diagnostics.
• Notable clients and projects. HTD designed and built the 510(k)-approved companion mobile application for Vave, a wireless, handheld ultrasound device.

Empeek: HIPAA and IEC 62304-Compliant Medical Device Software for U.S. Healthcare Providers

• Headquarters: Lviv, Ukraine (clients primarily in the U.S.)
• Founded: 2015
• Best for: U.S.-based healthcare providers and MedTech companies that need medical device software built to FDA and IEC 62304 standards, with a focus on automating clinical workflows and reducing administrative burden.

Empeek is a 150+ person team of Ukrainian software specialists building custom medical solutions for U.S. providers. They target overlooked bottlenecks in care delivery, from cumbersome insurance workflows to error-prone medication systems. Their device work spans embedded software, SaMD applications, and IoMT-connected clinical tools for regulated U.S. environments.

• Regulatory compliance. Empeek follows FDA medical device guidance across SaMD and manufacturing software, with documentation aligned to IEC 62304, ISO 13485, and 21 CFR Part 820, depending on device class and market. Each project includes early risk assessment, traceability matrices, and audit-ready documentation.
• Pharma and MedTech AI solutions. Empeek builds intelligent medication management systems, IoMT-connected patient monitoring, and clinical workflow automation, with HIPAA and FDA requirements embedded at the architecture level.
• Notable clients and projects. They have delivered IoMT and connected device software for U.S. providers, including chronic condition management tools that plug into clinical workflows and stream real-time patient data to care teams.

Pharma Data Platforms and Real-World Evidence AI Partners

Real-world evidence now sits at the center of drug development and post-market surveillance. FDA’s RWE Program, the EU’s DARWIN EU initiative, and payer outcomes research require platforms that can ingest, harmonize, and analyze data from EHRs, claims databases, registries, and wearables. The vendors below have delivered production platforms in this environment.

EPAM Systems: GxP-Ready Data Platforms and Federated RWE Infrastructure for Pharma

• Headquarters: Newtown, Pennsylvania (global delivery centers across 55+ countries).
• Founded: 1993.
• Best for: Large pharma and biopharma organizations that need enterprise-scale AI data platforms, federated real-world evidence infrastructure, and GxP-compliant clinical analytics.

EPAM delivers strategies and solutions for global pharmaceutical companies across the full product lifecycle. Their life sciences practice is highly documented and strengthened by dedicated RWE capabilities from the Odysseus Data Services acquisition and an open-source clinical trial toolchain.

• Regulatory compliance. EPAM CORA™ is a secure, GxP-ready platform built for AWS HealthOmics. It enables life sciences and healthcare teams to analyze multimodal omics data at scale through population sequencing, high-throughput bioinformatics, and collaborative workflows. Via Odysseus, EPAM provides RWE solutions with data standardized to OMOP, FHIR, and SDTM.
• Pharma and MedTech AI solutions. Their AWS-based platforms integrate diverse datasets into unified environments, powering advanced analytics, accelerating precision medicine, and enabling cloud-native HPC migration for compute-intensive pharma research. AI work spans drug discovery, pharmacovigilance, clinical trial data analytics, and agentic AI for clinical operations.
• Notable clients and projects. EPAM partnered with the digital Experimental Cancer Medicine Team on ACUITY, an open-source tool for Phase 1 and 2 oncology trial data analysis, now used across 10 active clinical trials, including COVID-19 observational studies at a UK research hospital.

Luxoft: Clinical Trial Data Management and Pharma Process Automation at Enterprise Scale

• Headquarters: Zug, Switzerland (global delivery centers; DXC Technology subsidiary).
• Founded: 2000.
• Best for: Large pharma and biotech organizations that need clinical trial data management, regulatory process automation, and AI-enabled drug development platforms built at enterprise scale.

Luxoft leverages its IT integration expertise and experience providing software services to major pharmaceutical companies across 42 global delivery centers to implement life sciences platforms. As a DXC Technology subsidiary, they bring enterprise infrastructure scale to pharma AI projects that require long-term vendor stability and global delivery capacity.

• Regulatory compliance. Luxoft’s pharma practice covers clinical trial data capture, management, and reporting alongside PHI/PII master data management. Compliance is built on Appian-based process automation for regulatory workflows and chain-of-custody data governance from discovery through disposal.
• Pharma and MedTech AI solutions. The AI expertise covers intelligent reporting applications for clinical data, population research analytics, sentiment analysis for pharma commercial teams, and process automation for regulatory submissions.
• Notable clients and projects. Luxoft partnered with Appian to help life sciences companies implement platforms that streamline clinical operations, manage regulatory compliance in real time, and accelerate time-to-market.

Final Thoughts

Pharma and MedTech AI projects fail more often at the vendor selection stage than at the technical stage. GxP, 21 CFR Part 11, IEC 62304, and MDR frameworks are constraints that must shape the architecture from the earliest decision.

The vendors in this guide were selected because they’ve worked inside these constraints in production environments. Match the segment to your use case, verify the regulatory depth, and hold every vendor to the same questions. The ones that answer without redirecting to HIPAA when you ask about GxP are worth moving forward with.

Sameer

Sameer is a writer, entrepreneur and investor. He is passionate about inspiring entrepreneurs and women in business, telling great startup stories, providing readers with actionable insights on startup fundraising, startup marketing and startup non-obviousnesses and generally ranting on things that he thinks should be ranting about all while hoping to impress upon them to bet on themselves (as entrepreneurs) and bet on others (as investors or potential board members or executives or managers) who are really betting on themselves but need the motivation of someone else’s endorsement to get there. Sameer is a writer, entrepreneur and investor. He is passionate about inspiring entrepreneurs and women in business, telling great startup stories, providing readers with actionable insights on startup fundraising, startup marketing and startup non-obviousnesses and generally ranting on things that he thinks should be ranting about all while hoping to impress upon them to bet on themselves (as entrepreneurs) and bet on others (as investors or potential board members or executives or managers) who are really betting on themselves but need the motivation of someone else’s endorsement to get there.

See Full Bio